Skip to main navigation Skip to search Skip to main content

Affinity hemodialysis for antiviral therapy. II. Removal of HIV-1 viral proteins from cell culture supernatants and whole blood

  • Aethlon Medical, Inc.

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Background: HIV-1 gp120 may play a role in the progression from HIV infection to AIDS. Aims: We investigated affinity hemodialysis for removing gp120 from cell culture and whole blood. Methods: Anti-gp120 antibodies covalently coupled to agarose beads were packed into columns or hollow-fiber hemodialysis cartridges. Supernatants from HIV-infected HL2/3 cells or gp120 containing whole blood were pumped over the columns and gp120 measured by ELISA. Results: Anti-gp120 agarose removed ∼90% of HIV-1 gp120 from HL2/3 cultures in 30-60 min. Capture was antibody-dependent (F105>IDX 1121>ABI 13-108). Affinity hemodialysis also efficiently captured gp120 from buffer in a first-order, flow-rate-dependent fashion (t1/2 = 13 min at 0.9 ml/min). Clearance was faster than calculated diffusion (t1/2 ∼2.5 h) suggesting significant convective transport. gp120 removal from blood was slower (t1/2 = 1.4 h). Conclusion: Affinity hemodialysis efficiently clears gp120 from cell culture fluids and blood and may be useful in slowing the progression to AIDS.

Original languageEnglish
Pages (from-to)58-63
Number of pages6
JournalBlood Purification
Volume21
Issue number1
DOIs
StatePublished - 2003

Keywords

  • Affinity hemodialysis
  • Blood
  • gp120
  • HIV-1
  • Removal

Fingerprint

Dive into the research topics of 'Affinity hemodialysis for antiviral therapy. II. Removal of HIV-1 viral proteins from cell culture supernatants and whole blood'. Together they form a unique fingerprint.

Cite this